References
- Bradley JG, Davis KA. Orthostatic hypotension. Am Fam Physician 2003; 68: 2393–2398
- Tranquilli WJ, Benson GJ. Advantages and guidelines for alpha-2 agonists as anesthetic adjuvants. Vet Clin North Am Small Anim Pract 1992; 22: 289–293
- Paddleford RR, Harvey RC. Alpha-2 agonists and antagonists. Vet Clin North Am Small Anim Pract 1999; 29: 737–745
- Hoffmann U, Meister CM, Golle K, Zschiesche M. Severe intoxication with the veterinary tranquilizer xylazine in humans. J Anal Toxicol 2001; 25: 245–249
- Mittleman RE, Hearn WL, Hime GW. Xylazine toxicity—literature review and report of two cases. J Forensic Sci 1998; 43: 400–402
- Capraro AJ, Wiley II JF, Tucker JR. Severe intoxication from xylazine inhalation. Pediatr Emerg Care 2001; 17: 447–448
- Spoerke DG, Hall AH, Grimes MJ, Honea BN, III, Rumack BH. Human overdose with the veterinary tranquilizer xylazine. Am J Emerg Med 1986; 4: 222–224
- Elejalde JI, Louis CJ, Elcuaz R, Pinillos MA. Drug abuse with inhalated xylazine. Eur J Emerg Med 2003; 10: 252–253
- Gallanosa AGE, Spyker DA, Shipe JR. Human xylazine overdose: A comparative review with clonidine, phenothiazines, and tricyclic antidepressants. Clin Toxicol 1981; 18: 663–678
- Barile FA. Sedative/Hypnotics. Clinical toxicology: Principles and mechanisms. 2003; 109–20
- Capel MM, Colbridge MG, Henry JA. Overdose profiles of new antipsychotic agents. Int J Neuropsychopharmacol 2000; 3: 51–54
- Rossi F, Forgione A. Pharmacotoxicological aspects of levosulpiride. Pharmacol Res 1995; 31: 81–94
- Arican FO, Okan T, Badak O, Guneri S. An unusual presentation from xylazine-ketamine. Vet Hum Toxicol 2004; 46: 324–325